Search research articles
联系我们
Search research articles
Search
相关实验视频
对威尔逊病的查.
I Matsuda
Lancet (London, England)
|
March 11, 1978
中文
概括
No abstract available in
PubMed
.
相关概念视频
您也可能阅读
相关文章
通过共同作者、期刊和引用图与本文相关的文章。
排序
全部
12
Same author
6
Same journal
6
Same author
Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis.
Nature genetics
·
1996
Same author
Gene therapy for ornithine transcarbamylase deficiency.
Acta paediatrica Japonica : Overseas edition
·
1996
Same author
The heparin-bound fraction of human lipoprotein-deficient serum inhibits endocytic uptake of oxidized low density lipoprotein by macrophages.
Atherosclerosis
·
1996
Same author
Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells.
Blood
·
1996
Same author
[Gene therapy for ornithine transcarbamylase deficiency].
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme
·
1995
Same author
Splicing mutations in the COL4A5 gene in Alport's syndrome: different mRNA expression between leukocytes and fibroblasts.
American journal of kidney diseases : the official journal of the National Kidney Foundation
·
1995
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)
·
2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)
·
2026
Same journal
Research priorities for characterising Bundibugyo virus.
Lancet (London, England)
·
2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)
·
2026
Same journal
Dual mobility total hip replacement in fractures: stability promotes patient confidence.
Lancet (London, England)
·
2026
Same journal
Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.
Lancet (London, England)
·
2026
查看所有相关文章